Expertise in

conditions

Reinhard Dummer

Zurich, ZH, CH

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Zurich, ZH, CH

Overview

Reinhard Dummer practices practicing medicine in Zurich, Switzerland.

Mr. Dummer is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Cutaneous T-Cell Lymphoma (CTCL), and T-Cell Lymphoma.

He is actively involved in clinical research, co-authoring 665 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Zurich, ZH, Switzerland

Other Locations

Kantonsspital Aarau
Aarau, AG 5000, Switzerland

Schlieren, ZH, Switzerland

Schlieren / Spital, ZH 8091, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-label, Phase I/II Study of T3P-Y058-739, a Genetically-modified Strain of the Bacterium Yersinia Enterocolitica, in Patients With Advanced Solid Tumours

Enrollment Status: Recruiting

Publish Date: April 13, 2026

Intervention Type: Drug

Study Phase: Phase 1/Phase 2

A Phase 1/2, FIH, Two-part, Open-label Clinical Trial of Intravenous (IV) Administration of CTL-002 Given as Monotherapy and/or in Combination With an Anti-PD-1 Checkpoint Inhibitor in Subjects With Advanced-stage, Relapsed/Refractory Solid Tumors (The GDFATHER-Trial: GDF-15 Antibody-mediaTed Human Effector Cell Relocation).

Enrollment Status: Active_not_recruiting

Publish Date: August 19, 2026

Intervention Type: Biological

Study Phase: Phase 1/Phase 2

A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma

Enrollment Status: Completed

Publish Date: March 17, 2026

Intervention Type: Biological, Drug

Study Drugs: IMCgp100, Dacarbazine, Ipilimumab, Pembrolizumab

Study Phase: Phase 2

A Three Arms Prospective, Randomized Phase II Study to Evaluate the Best Sequential Approach With Combo Immunotherapy (Ipilimumab/Nivolumab) and Combo Target Therapy (LGX818/MEK162) in Patients With Metastatic Melanoma and BRAF Mutation

Enrollment Status: Completed

Publish Date: June 07, 2024

Intervention Type: Drug

Study Drugs: LGX818, MEK162, Nivolumab, Ipilimumab

Study Phase: Phase 2

A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma

Enrollment Status: Completed

Publish Date: December 21, 2023

Intervention Type: Combination product

Study Drug: Melphalan/Hepatic Device System

Study Phase: Phase 3

An Open-label, Treatment-option Protocol of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma, or CD30-positive Cutaneous T-cell Lymphoma

Enrollment Status: No_longer_available

Publish Date: September 21, 2020

Intervention Type: Drug

Adjuvant Pegylated-Interferon-alpha2b (SylatronTM) for 2 Years Versus Observation in Patients With an Ulcerated Primary Cutaneous Melanoma With T(2-4)bN0M0: a Randomized Phase III Trial of the EORTC Melanoma Group.

Enrollment Status: Unknown

Publish Date: March 04, 2019

Intervention Type: Biological

Study Drug: PEG IFN Alfa-2b

Study Phase: Phase 3

View 6 Less Clinical Trials

665 Total Publications

Bullous eruption in the elderly - a case report with diagnostic challenges

Journal: Praxis

Published: September 08, 2026

View All 665 Publications

Frequently Asked Questions about Reinhard Dummer

Is Reinhard Dummer a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Reinhard Dummer is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Reinhard Dummer participate in research or clinical trials?

Yes. Reinhard Dummer has published 665 articles and abstracts on conditions like Melanoma. You can view a list of Reinhard Dummer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dummer's expertise for a condition

ConditionClose